OSTEOCLASTOMA (GIANT CELL TUMOUR)

OSTEOCLASTOMA (GIANT CELL TUMOUR)


OSTEOCLASTOMA (GIANT CELL TUMOUR)

  • Giant cell tumour (GCT) is a common bone tumour with variable growth potential.
  • Though generally classified as benign, it tends to recur after local removal.
  • Frankly malignant variants are also known.
  • Malignancy in GCT- Osteosarcoma or Malignant Fibrous Histiocytoma or Fibrosarcoma.

PATHOLOGY

  • The cell of origin is uncertain.
  • Microscopically, the tumour consists of undifferentiated spindle cells, profusely interspersed with multi-nucleate giant cells.
  • The tumour stroma is highly vascular.
  • These giant cells were mistaken as osteoclasts in the past, hence the name osteoclastoma.

CLINICAL FEATURES

  • The tumour is seen commonly in the age group of 20-40 years i.e., after epiphyseal fusion.
  • The bones affected commonly are those around the knee i.e., lower-end of the femur and upper-end of the tibia.
  • Lower-end of the radius is another common site.
  • The tumour is located at the epiphysis.
  • It often reaches almost up to the joint surface.
  • Common presenting complaints are swelling and vague pain.
  • Sometimes, the patient, unaware of the lesion, presents for the first time with a pathological fracture through the lesion.
EXAMINATION
  • Examination reveals a bony swelling, eccentrically located at the end of the bone.
  • Surface of the swelling is smooth.
  • There may be tenderness on firm palpation.
  • A characteristic ‘egg-shell crackling’ is often not elicited.
  • The limb may be deformed if a pathological fracture has occurred.

DIAGNOSIS

  • GCT is one of the common cause of a solitary lytic lesion of the bone, and must be differentiated from other such lesions.

Following are some of the characteristic radiological features of this tumour:

  • A solitary, may be loculated, lytic lesion.
  • Eccentric location, often subchondral.  

  • Expansion of the overlying cortex (expansile lesion).
  • ‘Soap-bubble’ appearance – the tumour is homogeneously lytic with trabeculae of the remnants of bone traversing it, giving rise to a loculated appearance.
  • No calcification within the tumour.  

 

  • None or minimal reactive sclerosis around the tumour.
  • Cortex may be thinned out, or perforated at places.
  • Tumour usually does not enter the adjacent joint.

TREATMENT

  • Wherever possible, excision of the tumour is the best treatment.
  • For sites like the spine, where excision is sometimes technically not possible, radiotherapy is done.
  • Following treatment methods are commonly used:

a) Excision: This is the treatment of choice when the tumour affects a bone whose removal does not hamper with functions e.g., the fibula, lower-end of the ulna etc.

b) Excision with reconstruction: When excision of a tumour at some site may result in significant functional impairment, the defect created by excision is made up, usually partially, by some reconstructive procedure.

  • For example, in tumours affecting the lower-end of femur, the affected part is excised en bloc, and the defect thus created made up by one of the following methods:

Arthrodesis by the Turn-o-Plasty procedure:

  • In this technique, the required length of the tibia is split into two halves.
  • One half is turned upside down and fixed with the stump of the femur left after excising the tumour.
  • A similar procedure can be used for a tibial lesion by taking half of the femur.

Arthrodesis by bridging the gap by double fibulae , one taken from same extremity and the other from the opposite leg.

Arthroplasty: In this procedure, the tumour is excised, and an attempt is made to reconstruct the joint in some way.

  • This can be carried out using an autograft (patella to substitute the articular defect), allograft (replacing the defect with the preserved bone of a cadaver), or an artificial joint (prosthesis).

c) Curettage with or without supplementary procedures: Curettage performed alone has the disadvantage of a high recurrence rate.

d) Amputation: For more aggressive tumours, or following recurrence, amputation may be necessary.

e) Radiotherapy: It is the preferred treatment method for GCT affecting the vertebrae.

  • Treatment for GCT at commoner sites is as given in Table
Site Treatment of choice
Lower end of femur Excision with Turn-o-Plasty
Upper end of tibia Excision with Turn-o-Plasty
Lower end of radius Excision with fibular grafting
Lower end of ulna Excision
Upper end of fibula Excision

Exam Important

  • Giant cell tumor is an epiphyseal tumor.
  • GCT seen commonly in the age group of 20-40 years
  • Soap bubble appearance  on X-ray is seen in Giant cell tumor.
  • GCT malignant component is Mononuclear cells.
  • Giant cell variants (Tumor with giant cells):
  1. Brown tumor of hyper parathyroidism
  2. Aneurysmal bone cyst (closest)
  3. Non-ossifying fibroma (commonest)
  4. Fibrosarcoma
  • Osteoclastoma is treated with Joint replacement, Excision, Curettage, Arthrodesis.
Don’t Forget to Solve all the previous Year Question asked on OSTEOCLASTOMA (GIANT CELL TUMOUR)
Click Here to Start Quiz

Module Below Start Quiz

Leave a Reply

Discover more from New

Subscribe now to keep reading and get access to the full archive.

Continue reading

👨‍⚕️
Chat Support